Amy Garabedian
Conseiller Juridique Général chez LAVA THERAPEUTICS N.V.
Fortune : 152 548 $ au 31/05/2024
Provenance du réseau au premier degré de Amy Garabedian
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 25 | |
| Subsidiary | Biotechnology | 24 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Amy Garabedian via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Founder Chief Operating Officer | |
| University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder Director/Board Member | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Perelman School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Innovative Genomics Institute | Director/Board Member Director/Board Member | ||
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Compliance Officer Corporate Officer/Principal | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| GENMARK DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Amsterdam | College/University | Doctorate Degree Doctorate Degree | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Masters Business Admin Doctorate Degree | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Operating Officer | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| IGNYTA INC | Biotechnology | Chief Executive Officer Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
| Erivan K. Haub School of Business | College/University | Masters Business Admin | |
PanAgora Asset Management, Inc.
 PanAgora Asset Management, Inc. Investment ManagersFinance PanAgora Asset Management, Inc. (PAM) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is a subsidiary of PanAgora Holdings, Inc., ultimately held by Power Corp. of Canada (TSE: POW) in Canada. PAM is the sponsor and investment manager for certain private unregistered investment pools, such as funds organized under US tax-qualified group trusts, domestic private funds organized as limited liability companies, and offshore private funds organized as Cayman Islands exempted companies. They also provide investment advisory services to institutional separate account clients. | Investment Managers | Analyst-Equity | |
| Pharmacia GmbH | Private Equity Investor | ||
| CODEMILL AB | Packaged Software | Comptroller/Controller/Auditor | |
Pfizer Pharmaceuticals Ltd.
 Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 37 |
| Royaume-Uni | 7 |
| Pays-Bas | 4 |
| Suisse | 2 |
| France | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 298 |
| Corporate Officer/Principal | 124 |
| Independent Dir/Board Member | 104 |
| Chairman | 47 |
| Chief Executive Officer | 39 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Noble | 39 |
| Kapil Dhingra | 39 |
| Robert Perez | 31 |
| Karen Wilson | 31 |
| Nanna Liebach Lüneborg | 29 |
| Steven Altschuler | 27 |
| Peter Kiener | 25 |
| Guido Magni | 23 |
| Stephen Webster | 23 |
| Lars Ekman | 21 |
| Charles Sigal | 20 |
| Lota Zoth | 20 |
| Anand Mehra | 18 |
| Joël Jean-Mairet | 17 |
| Stephen Allen Hurly | 16 |
- Bourse
- Insiders
- Amy Garabedian
- Connexions Sociétés
